144 related articles for article (PubMed ID: 29071402)
1. Acquired Genetic and Epigenetic Variation in Human Pluripotent Stem Cells.
Kyriakides O; Halliwell JA; Andrews PW
Adv Biochem Eng Biotechnol; 2018; 163():187-206. PubMed ID: 29071402
[TBL] [Abstract][Full Text] [Related]
2. Generation of human oogonia from induced pluripotent stem cells in vitro.
Yamashiro C; Sasaki K; Yabuta Y; Kojima Y; Nakamura T; Okamoto I; Yokobayashi S; Murase Y; Ishikura Y; Shirane K; Sasaki H; Yamamoto T; Saitou M
Science; 2018 Oct; 362(6412):356-360. PubMed ID: 30237246
[TBL] [Abstract][Full Text] [Related]
3. End-to-End Platform for Human Pluripotent Stem Cell Manufacturing.
Pandey PR; Tomney A; Woon MT; Uth N; Shafighi F; Ngabo I; Vallabhaneni H; Levinson Y; Abraham E; Friedrich Ben-Nun I
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877727
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic instability in human pluripotent stem cells.
Nguyen HT; Geens M; Spits C
Hum Reprod Update; 2013; 19(2):187-205. PubMed ID: 23223511
[TBL] [Abstract][Full Text] [Related]
5. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
6. Laser-assisted generation of human induced pluripotent stem cells.
Liu Y; Wu D; Lao D; Peterson C; Hohenstein Elliott KA; Snyder EY
Curr Protoc Stem Cell Biol; 2014 Nov; 31():4A.7.1-15. PubMed ID: 25366899
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation dynamics in human induced pluripotent stem cells.
Nishino K; Umezawa A
Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573
[TBL] [Abstract][Full Text] [Related]
8. Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease.
Imm J; Kerrigan TL; Jeffries A; Lunnon K
Epigenomics; 2017 Nov; 9(11):1455-1468. PubMed ID: 28969469
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic aberrations in human pluripotent stem cells.
Bar S; Benvenisty N
EMBO J; 2019 Jun; 38(12):. PubMed ID: 31088843
[TBL] [Abstract][Full Text] [Related]
10. Purification of functional reprogramming factors in mammalian cell using FLAG -Tag.
Han MJ; Kim HR; O'Reilly C; Kim CH
Biochem Biophys Res Commun; 2017 Oct; 492(2):154-160. PubMed ID: 28802578
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A.
Suchorska WM; Augustyniak E; Richter M; Trzeciak T
Mol Med Rep; 2017 May; 15(5):2387-2401. PubMed ID: 28447755
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
13. Generation, Expansion, and Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) Derived From the Umbilical Cords of Newborns.
Song RS; Carroll JM; Acevedo L; Wu D; Liu Y; Snyder EY
Curr Protoc Stem Cell Biol; 2014 May; 29():1C.16.1-13. PubMed ID: 24838913
[TBL] [Abstract][Full Text] [Related]
14. The safety of human pluripotent stem cells in clinical treatment.
Simonson OE; Domogatskaya A; Volchkov P; Rodin S
Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
16. Nonintegrating Human Somatic Cell Reprogramming Methods.
Schlaeger TM
Adv Biochem Eng Biotechnol; 2018; 163():1-21. PubMed ID: 29075799
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cells: Generation, Characterization, and Differentiation--Methods and Protocols.
Graversen VK; Chavala SH
Methods Mol Biol; 2016; 1357():395-401. PubMed ID: 25403469
[TBL] [Abstract][Full Text] [Related]
19. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
Abraham S; Sheridan SD; Miller B; Rao RR
Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
[TBL] [Abstract][Full Text] [Related]
20. cGMP-Compliant Expansion of Human iPSC Cultures as Adherent Monolayers.
Parr AM; Walsh PJ; Truong V; Dutton JR
Methods Mol Biol; 2016; 1357():221-9. PubMed ID: 25863788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
